# Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions

> **NCT07737171** · — · RECRUITING · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 60 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DEVICE:** Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA)

## Key facts

- **NCT ID:** NCT07737171
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-07
- **Primary completion:** 2033-04-01
- **Final completion:** 2033-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737171, "Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07737171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*